Vitamin K epoxide reductase regulation of androgen receptor activity
Open Access
- 13 January 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (8) , 13818-13831
Abstract
Vitamin K epoxide reductase regulation of androgen receptor activity Vitamin K epoxide reductase regulation of androgen receptor activityKeywords
This publication has 50 references indexed in Scilit:
- Posttranslational Modification of the Androgen Receptor in Prostate CancerInternational Journal of Molecular Sciences, 2013
- Human SREBP1c Expression in Liver Is Directly Regulated by Peroxisome Proliferator-activated Receptor α (PPARα)Journal of Biological Chemistry, 2011
- Novel Insight into the Mechanism of the Vitamin K Oxidoreductase (VKOR)Journal of Biological Chemistry, 2011
- The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cellsExperimental Cell Research, 2010
- Non-competitive androgen receptor inhibition in vitro and in vivoProceedings of the National Academy of Sciences, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- The Role of SPINK1 in ETS Rearrangement-Negative Prostate CancersCancer Cell, 2008
- Cell- and gene-specific regulation of primary target genes by the androgen receptorGenes & Development, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activationBritish Journal of Pharmacology, 2004